Select for export Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/374199 Copy citation Copy BibTeX bioRxiv 2018-07-24 Awan AR, Winter JM, Turner D, Shaw WM, Suz LM, Bradshaw AJ bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionAddictionEnd-of-Life Distress Other More
Select for export Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s40262-017-0540-6 PubMed 28353056 Copy citation Copy BibTeX Clinical Pharmacokinetics 2017-11-30 Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D Europe PMC Published psilocybinpsilocin DepressionAddictionPharmacology Clinical Trial More
Select for export Challenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.acc.2016.07.004 PubMed 28057187 Copy citation Copy BibTeX Unknown journal 2016-08-31 Dasgupta A. Europe PMC Published psilocybinpsilocin General Other More
Select for export A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.14704/nq.2016.14.2.943 Copy citation Copy BibTeX NeuroQuantology 2016-05-23 Joseph A. Zamaria OpenAlex Published psilocybin DepressionAnxietyOCD Other More
Select for export Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(15)00576-3 PubMed 27067625 Copy citation Copy BibTeX Unknown journal 2016-04-04 Mithoefer MC, Grob CS, Brewerton TD. Europe PMC Published psilocybin AnxietyPTSDAddiction Randomized Controlled Trial More
Select for export Psychedelics not linked to mental health problems or suicidal behavior: a population study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114568039 PubMed 25744618 Copy citation Copy BibTeX Journal of Psychopharmacology 2015-03-04 Johansen PØ, Krebs TS. Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Stanislav Grof's Contributions to FDA Drug Development Research with Psychedelics Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX CIIS Digital Commons (California Institute of Integral Studies) 2013-12-31 Rick Doblin OpenAlex Published psilocybin AnxietyPTSDAddiction Clinical Trial More
Select for export PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A2014 REPORT Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2013-12-31 Robert L. Jesse, Roland R. Griffi OpenAlex Published psilocybin AddictionWellbeingSpirituality Observational Study More
Select for export Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2012.736842 PubMed 23457892 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2012-10-31 Lyvers M, Meester M. Europe PMC Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881111420188 PubMed 21956378 Copy citation Copy BibTeX Journal of Psychopharmacology 2011-09-27 MacLean KA, Johnson MW, Griffiths RR. Europe PMC Published psilocybin Personality ChangeCreativitySpirituality Randomized Controlled Trial More
Select for export Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-011-2358-5 PubMed 21674151 Copy citation Copy BibTeX Psychopharmacology 2011-06-14 Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Europe PMC Published psilocybin AnxietySpiritualityMystical Experience Clinical Trial More
Select for export Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/archgenpsychiatry.2010.116 PubMed 20819978 Copy citation Copy BibTeX Archives of General Psychiatry 2010-09-05 Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL Europe PMC Published psilocybin DepressionAnxietyAging Other More
Select for export [Student's use of illicit drugs: a survey in a preventive health service]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0013-7006(09)73471-2 PubMed 20141772 Copy citation Copy BibTeX Unknown journal 2009-11-30 Morvan Y, Rouvier J, Olié JP, Lôo H, Krebs MO. Europe PMC Published psilocybin AnxietyAddictionPersonality Change Observational Study More
Select for export Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881108094300 PubMed 18593735 Copy citation Copy BibTeX Journal of Psychopharmacology 2008-06-30 Griffiths R, Richards W, Johnson M, McCann U, Jesse R. Europe PMC Published psilocybin WellbeingPersonality ChangeSpirituality Observational Study More
Select for export [Hallucinogen-induced psychological disorders]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2008-1038191 PubMed 18512184 Copy citation Copy BibTeX Unknown journal 2008-05-31 Hermle L, Kovar KA, Hewer W, Ruchsow M. Europe PMC Published psilocybin Review ArticleAdolescents Review Article More
Select for export Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-006-0457-5 PubMed 16826400 Copy citation Copy BibTeX Psychopharmacology 2006-07-06 Griffiths RR, Richards WA, McCann U, Jesse R. Europe PMC Published psilocybin AnxietySpiritualityMystical Experience Observational Study More
Select for export [Hallucinogens, amphetamines and entactogens]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1024/0040-5930.60.6.323 PubMed 12848067 Copy citation Copy BibTeX Unknown journal 2003-05-31 Vollenweider FX, Vollenweider-Scherpenhuyzen MF. Europe PMC Published psilocybin Emotional ProcessingObservational StudySafety Observational Study More
Select for export Psychoactive mushroom use in Koh Samui and Koh Pha-Ngan, Thailand. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/0378-8741(92)90020-r PubMed 1548895 Copy citation Copy BibTeX Unknown journal 1991-12-31 Allen JW, Merlin MD. Europe PMC Published psilocybinpsilocin Chronic PainAnimal Study Animal Study More
Select for export Hallucinogenic mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/000992288802700202 PubMed 3338231 Copy citation Copy BibTeX Unknown journal 1988-01-31 Schwartz RH, Smith DE. Europe PMC Published psilocybin PharmacologyReview ArticleAdolescents Review Article More